$4.16
0.020.48%
마지막 업데이트: Oct 21, 7:36 PM
$4.16
0.020.48%
Benzinga
Benzinga
Benzinga
목요일, 10월 22
Benzinga
© 2026 Benzinga | All Rights Reserved
Coya Therapeutics (COYA) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.36 | $-0.39 | $-0.21 | $-0.17 |
| Actual | $-0.28 | $-0.32 | $-0.34 | $-0.13 |
| Surprise | +22.2% | +17.9% | -61.9% | +23.5% |
| Revenue | ||||
| Estimate | $104290 | $71670 | $3.1M | $5.6M |
| Actual | $243745 | $251147 | $4.0M | $3.6M |
| Surprise | +133.7% | +250.4% | +27.1% | -36.1% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.35 | $-0.38 | $-0.47 | $-0.48 |
| Revenue | ||||
| Consensus | $78570 | $471430 | — | — |
| 회계 분기 | 보고된 날짜 | 실제 EPS | 예상 EPS | 놀라다 % |
|---|---|---|---|---|
| Q2 | Aug 11, 2026 | $-0.28 | $-0.36 | 22.2 % |
| Q1 | May 12, 2026 | $-0.32 | $-0.39 | 17.9 % |
| Q4 | Mar 16, 2026 | $-0.34 | $-0.21 | -61.9 % |
| Q3 | Nov 12, 2025 | $-0.13 | $-0.17 | 23.5 % |
| 회계 분기 | 보고된 날짜 | 실제 수익 | 예상 수익 | 놀라다 % |
|---|---|---|---|---|
| Q2 | Aug 11, 2026 | $243.75K | $104.29K | 133.7 % |
| Q1 | May 12, 2026 | $251.15K | $71.67K | 250.4 % |
| Q4 | Mar 16, 2026 | $3.96M | $3.12M | 27.1 % |
| Q3 | Nov 12, 2025 | $3.56M | $5.58M | -36.1 % |